Drug intelligence / Profile preview

echinacea purpurea extract

Development stage
Phase 4
Lead developer
A. Vogel
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Echinacea purpurea extract is a botanical preparation derived from the aerial parts and roots of the Echinacea purpurea plant, commonly known as the purple coneflower. It is widely used as a dietary supplement for its **immunomodulatory**, **anti-inflammatory**, **antiviral**, and **antioxidant** properties, with primary indications including the prevention and treatment of upper respiratory tract infections such as the common cold and influenza[1][3][4][6][7]. Echinacea purpurea extract contains several classes of secondary metabolites, including alkamides, caffeic acid derivatives (notably cichoric acid), and polysaccharides, believed to contribute to its biological activity[1][4]. Its mechanism of action is attributed to activation of innate immune responses—stimulating phagocytosis, increasing the activity and mobility of macrophages, neutrophils, dendritic cells, and natural killer cells; it also upregulates cytokines such as IL-2, IFN-γ, and TNF-α[1][4][6]. Alkamides may exert effects via binding to the cannabinoid receptor type 2 (CB2), mediating immunomodulation, and by inhibiting the pro-inflammatory cytokine TNF-α[1][4]. Clinical trials support its immune-enhancing capability and generally favorable safety profile for short- to moderate-term use, although some rare adverse events have been reported[1][3][6].

Brand names
Echinaforce
Other names
Echinacea purpurea extractEchinacea extractPurple coneflower extractEPE
02

Targets

CB (Cannabinoid receptors)

Beyond the preview

Go deeper on echinacea purpurea extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on echinacea purpurea extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call